Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (1)
- (34)
- (444)
- (55)
- (2)
- (2)
- (2)
- (3)
- (5)
- (258)
- (1)
- (1)
- (153)
- (14)
- (2)
- (1)
- (628)
- (62)
- (4)
- (1)
- (8)
- (1)
- (3)
- (1)
- (11)
- (2)
- (1)
- (1)
- (1)
- (1)
- (4)
- (13)
- (2)
- (4)
- (1)
- (1)
- (119)
- (79)
Form
- (2)
- (38)
- (1,151)
Recombinant
- (1,170)
Conjugate
- (1,133)
Species
- (1)
- (1)
- (267)
- (90)
- (8)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
1
–
15
of
551
results
Promotions Available
Gibco™ Human FGF-basic (FGF-2/bFGF) (aa 10-155) Recombinant Protein
Gibco™ Human FGF-basic (FGF-2/bFGF) (aa 10-155) Recombinant Protein
Recombinant Protein
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 10-155) |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Protein Form | Recombinant, Ligand, Truncated |
| Biological Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Research Category | Neurobiology, Oncology, Stem Cell Research, Microbiology, Differentiation, Angiogenesis |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | 4°C |
| Gene Symbol | FGF2 |
| Sequence | Human FGF-basic, amino acids 10-155 |
| Storage Requirements | 4°C |
| Protein Subtype | FGFs (Fibroblast Growth Factors) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Product Line | Gibco |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Activity | ED50 = 0.1 - 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 1-155) |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 = 0.1 - 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Research Category | Neurobiology, Oncology, Stem Cell Research, Microbiology, Differentiation, Angiogenesis |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Approved for shipment on Wet or Dry Ice |
| Content And Storage | 4°C |
| Gene Symbol | FGF2 |
| Sequence | Human FGF-basic, amino acids Met134-Ser288 with C211S and C229S substitutions and an N-terminal Gly-His |
| Storage Requirements | 4°C |
| Protein Subtype | FGFs (Fibroblast Growth Factors) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Product Line | Gibco |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-3 |
| Molecular Weight (g/mol) | 25 kDa |
| Gene Symbol | TGFB3 |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | ALDTNYCFRN LEENCCVRPL YIDFRQDLGW KWVHEPKGYY ANFCSGPCPY LRSADTTHST VLGLYNTLNP EASASPCCVP QDLEPLTILY YVGRTPKVEQ LSNMVVKSCK CS |
| Expression System | E. coli |
| For Use With (Application) | ELISA,Functional Assay,Western Blot |
| Source | E. coli |
| Name | Human TGF-beta 3 |
| Accession Number | P10600 |
| Regulatory Status | RUO |
| Gene Alias | ARVD; ARVD1; FLJ16571; H-TGF-b-3; LAP; Latency-associated peptide; LDS5; prepro-transforming growth factor beta-3; RNHF; TGF beta 3; Tgfb3; TGF-B3; Tgfb-3; TGF-beta3; TGF-beta-3; Transforming growth factor; transforming growth factor beta 3; transforming growth factor beta precursor; transforming growth factor beta-3; Transforming growth factor beta-3 proprotein; transforming growth factor, beta 3; transforming growth factor-beta3 |
| Biological Activity | The ED50 was determined by TGF-beta3's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7043 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-3 |
| Molecular Weight (g/mol) | 15 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 = 0.1 - 0.25 ng/mL; determined by the dose-dependent proliferation of human TF-1 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IL-3 |
| Purification Method | Purified |
| Gene Alias | BP/BPA; BPA; Colony stimulating factor multiple; colony-stimulating factor, multiple; Csfmu; Eo-CSF; HCGF; hematopoietic growth factor; Il3; Il-3; ILN; Interleukin; interleukin 3; Interleukin 3 (colony stimulating factor; Interleukin3; interleukin-3; Mast cell growth factor; mast-cell growth factor; MCGF; MGC79398; MGC79399; MGF; Multi CSF; MULTI-CSF; Multilineage colony stimulating factor; multilineage-colony-stimulating factor; multiple); multipotential colony-stimulating factor; P cell stimulating factor; P-cell stimulating factor; P-cell-stimulating factor; PCSA; PSF |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 = 0.1 - 0.25 ng/mL; determined by the dose-dependent proliferation of human TF-1 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Immunology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | IL3 |
| Sequence | APMTQTTPLK TSWVNCSNMI DEIITHLKQP PLPLLDFNNL NGEDQDILME NNLRRPNLEA FNRAVKSLQN ASAIESILKN LLPCLPLATA APTRHPIHIK DGDWNEFRRK LTFYLKTLEN AQAQQTTLSL AIF |
| Storage Requirements | 4°C |
| Protein Subtype | Interleukins |
| Accession Number | P08700 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 3562 |
| Product Line | Gibco |
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TNF alpha |
| Molecular Weight (g/mol) | 17.5 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human TNF-alpha |
| Purification Method | Purified |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Immunology, Signal Transduction, Stem Cell Research, Inflammation, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | Tnf |
| Sequence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Storage Requirements | 4°C |
| Protein Subtype | TNF (Tumor Necrosis Factor) |
| Accession Number | P01375 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 7124 |
| Product Line | Gibco |
Promotions Available
Gibco™ Human VEGF-165, Animal-Free Recombinant Protein, PeproTech®
Gibco™ Human VEGF-165, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Gene Symbol | Vegfa |
| Activity | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-8.0 ng/ml |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human VEGF-165, Animal-Free |
| Accession Number | P15692 |
| Regulatory Status | RUO |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 7422 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | >95% |
| Conjugate | Unconjugated |
| Form | Liquid |
| Common Name | WNT3A |
| Gene Symbol | WNT3A |
| Endotoxin Concentration | 1 EU/mL |
| Concentration | 2 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Functional Assay |
| Source | HEK293 cells |
| Name | Wnt Surrogate-Fc Fusion |
| Accession Number | P56704 |
| Regulatory Status | RUO |
| Gene Alias | MGC119418; MGC119419; MGC119420; Protein Wnt-3 A; vestigial tail; vt; wingless-related MMTV integration site 3 A; wingless-type MMTV integration site family member 3 A; wingless-type MMTV integration site family, member 3 like; wingless-type MMTV integration site family, member 3 A; Wnt 3 A; Wnt family member 3 A; wnt[a]; wnt3; wnt3 l; wnt3 like; Wnt3a; Wnt-3 A; WNT3A protein; wnt3l; Zwnt[a] |
| Biological Activity | Greater than 25 fold induction in Topflash assay activity (at a Wnt surrogate-Fc protein concentration between 0.03 - 5.0 nM (based on dimeric stoichiometry)) |
| Gene ID (Entrez) | 89780 |
| Formulation | 25 mM tris with 500 mM NaCl and no preservative; pH 8.2 |
| Recombinant | Recombinant |
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | SCF |
| Molecular Weight (g/mol) | 18.54 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 10 ng/mL; determined by the dose-dependent proliferation of human MO-7e cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human SCF |
| Purification Method | Purified |
| Gene Alias | 710-712; blz; c-Kit ligand; Clo; cloud gray; Con; contrasted; CSF; DCUA; DFNA69; DKFZp686F2250; familial progressive hyperpigmentation 2; FPH2; FPHH; Gb; grizzle-belly; hematopoietic growth factor KL; H-SCF; Kit ligand; Kitl; Kitlg; kit-ligand; KL-1; Mast cell growth factor; MGF; M-SCF; Processed kit ligand; SCF; SF; SHEP7; sKITLG; Sl; SLF; Soluble KIT ligand; Steel factor; steel factor/kit ligand; stem cell factor; stem cell factor KL-1; stem cell factor, CSF |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 10 ng/mL; determined by the dose-dependent proliferation of human MO-7 e cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | KITLG |
| Sequence | EGICRNRVTN NVKDVTKLVA NLPKDYMITL KYVPGMDVLP SHCWISEMVV QLSDSLTDLL DKFSNISEGL SNYSIIDKLV NIVDDLVECV KENSSKDLKK SFKSPEPRLF TPEEFFRIFN RSIDAFKDFV VASETSDCVV SSTLSPEKDS RVSVTKPFML PPVA |
| Storage Requirements | 4°C |
| Protein Subtype | Other Proteins |
| Accession Number | P21583 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 4254 |
| Product Line | Gibco |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | ≥95% by SDS-PAGE and HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 40 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 6 ng/mL; determined by the dose-dependent proliferation of HUVECs. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity |
| Name | Human VEGF-165 |
| Purification Method | Purified |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 6 ng/mL; determined by the dose-dependent proliferation of HUVECs. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Oncology, Angiogenesis, Stem Cell Research, Differentiation, Inflammation |
| Specific Activity | 1.0 x 106 - 1.7 x 105 units⁄mg |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Bioassay | Proliferation of HUVECs (Human Umbilical Vein Endothelial Cells) |
| Gene Symbol | Vegfa |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Storage Requirements | 4°C |
| Protein Subtype | VEGF (Vascular Endothelial Growth Factor) |
| Accession Number | P15692 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 7422 |
| Product Line | Gibco |
Promotions Available
Gibco™ Human TGF-beta 1, Animal-Free Recombinant Protein, PeproTech®
Gibco™ Human TGF-beta 1, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
| Accession Number | P01137 |
|---|---|
| Regulatory Status | RUO |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 7040 |
| Formulation | Protein with no preservative |
| Gene Symbol | Tgfb1 |
| Sequence | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Recombinant | Recombinant |
| Name | Human TGF-beta 1, Animal-Free |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa), Animal-Free |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
Promotions Available
Gibco™ Human/Mouse/Rat Activin A Recombinant Protein, PeproTech®
Gibco™ Human/Mouse/Rat Activin A Recombinant Protein, PeproTech®
Recombinant Protein
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene Symbol | Inhba |
| Sequence | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Name | Human/Mouse/Rat Activin A |
| Accession Number | P08476, P18331, Q04998 |
| Regulatory Status | RUO |
| Gene Alias | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Gene ID (Entrez) | 16323, 29200, 3624 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-AB |
| Molecular Weight (g/mol) | 26.4 kDa |
| Gene Symbol | PDGFA, PDGFB |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | Alpha chain: SIEEAVPAVC KTRTVIYEIP RSQVDPTSAN FLIWPPCVEV KRCTGCCNTS SVKCQPSRVH HRSVKVAKVE YVRKKPKLKE VQVRLEEHLE CACATTSLNP DYREEDTGRP RESGKKRKRK RLKPT Beta chain: SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Source | E. coli |
| Name | Human PDGF-AB |
| Accession Number | P01127, P04085 |
| Regulatory Status | RUO |
| Gene Alias | Becaplermin; c-sis; H-PDGF-AB; IBGC5; PDGF A-chain; PDGF subunit A; PDGF subunit B; PDGF, B chain; PDGF1; PDGF-1; PDGF2; PDGF-2; Pdgfa; PDGF-A; PDGFAB; PDGFB; PDGF-B; platelet derived growth factor subunit A; platelet derived growth factor subunit B; platelet derived growth factor, alpha; platelet derived growth factor, B polypeptide; platelet-derived growth factor 2; platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor B chain; platelet-derived growth factor beta polypeptide; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); platelet-derived growth factor subunit A; Platelet-derived growth factor subunit B; platelet-derived growth factor, beta polypeptide (oncogene SIS); proto-oncogene c-Sis; SIS; SSV |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of thymidine uptake by Balb/c 3T3 cells is ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 5154, 5155 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Interferon alpha-2 |
| Molecular Weight (g/mol) | 19.3 kDa |
| Gene Symbol | IFNA2 |
| Activity | Determined by a cytotoxicity assay using human TF-1 cells. |
| Endotoxin Concentration | <1 EU/ μg |
| Sequence | MCDLPQTHSL GSRRTLMLLA QMRKISLFSC LKDRHDFGFP QEEFGNQFQK AETIPVLHEM IQQIFNLFST KDSSAAWDET LLDKFYTELY QQLNDLEACV IQGVGVTETP LMKEDSILAV RKYFQRITLY LKEKKYSPCA WEVVRAEIMR SFSLSTNLQE SLRSKE |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | Human IFN-alpha 2 (alpha2a) |
| Accession Number | P01563 |
| Regulatory Status | RUO |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | alpha-2 A interferon; Ifa2; IFNA; IFN-a; IFNA 2; Ifna2; IFNA2A; IFNA2B; IFNA2C; IFN-alpha 1 b; IFN-alpha-1/13; IFN-alpha-2; IFN-alphaA; INFA2; Interferon; interferon alpha 1 b; interferon alpha 2; interferon alpha 2 A; interferon alpha 2 b; interferon alpha A; interferon alpha family, gene 2; interferon alpha-2; Interferon alpha-A; interferon alpha-D; interferon, alpha 2; Interferon-alpha II; leIF A; leIF D; RP11-354P17.2 |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by a cytotoxicity assay using human TF-1 cells. |
| Gene ID (Entrez) | 3440 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Accession Number | P01574 |
|---|---|
| Regulatory Status | RUO |
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 3456 |
| Formulation | Protein with no preservative |
| Gene Symbol | Ifnb1 |
| Sequence | MSYNLLGFLQ RSSNFQCQKL LWQLNGRLEY CLKDRMNFDI PEEIKQLQQF QKEDAALTIY EMLQNIFAIF RQDSSSTGWN ETIVENLLAN VYHQINHLKT VLEEKLEKED FTRGKLMSSL HLKRYYGRIL HYLKAKEYSH CAWTIVRVEI LRNFYFINRL TGYLRN |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Recombinant | Recombinant |
| Name | Human IFN-beta |